Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review

Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops and commercializes products and technologies to prevent the abuse and misuse of medication. The company’s proprietary technologies include, Aversion, Limitx and Impede technology. The company’s Limitx technology helps to minimize the risks associated with drug overdose and Aversion technology is to address methods of abuse associated with opioid analgesics. Its Impede technology helps minimize the extraction and conversion of pseudoephedrine into methamphetamine. Its product portfolio includes Oxaydo, an opioid analgesic; Nexafed and Nexafed Sinus Pressure plus that contain pseudoephedrine. The company markets products in the US and Canada. Acura is headquartered in Palatine, Illinois, the US.

Acura Pharmaceuticals Inc Key Recent Developments

Aug 16,2021: Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
May 17,2021: Acura Pharmaceuticals Announces First Quarter Ended March 31, 2021 Financial Results
Mar 31,2021: Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
Nov 16,2020: Acura Pharmaceuticals announces third quarter 2020 financial results
Aug 14,2020: Acura Pharmaceuticals announces second quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

LIST OF TABLES

Acura Pharmaceuticals Inc, Key Facts
Acura Pharmaceuticals Inc, Key Employees
Acura Pharmaceuticals Inc, Key Employee Biographies
Acura Pharmaceuticals Inc, Major Products and Services
Acura Pharmaceuticals Inc, History
Acura Pharmaceuticals Inc, Subsidiaries
Acura Pharmaceuticals Inc, Key Competitors
Acura Pharmaceuticals Inc, Ratios based on current share price
Acura Pharmaceuticals Inc, Annual Ratios
Acura Pharmaceuticals Inc, Annual Ratios (Cont...1)
Acura Pharmaceuticals Inc, Annual Ratios (Cont...2)
Acura Pharmaceuticals Inc, Interim Ratios
Acura Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acura Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acura Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Acura Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Acura Pharmaceuticals Inc, Ratio Charts
Acura Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acura Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021